Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cleveland › NPI 1215989611
Hospital

Fairview Hospital

Fairview Hospital was paid $62.42M by Medicaid between Jan 2018 and Dec 2024, across 520 billing codes. Its largest line is 99285, emergency room visit (most serious) — 14% of everything it billed.

33Billing provider infoFAIRVIEW HOSPITAL
CLEVELAND, OH 44111
33aNPI1215989611assigned 05/16/2006
28Total paid$62.42M
24GClaims1,486,783
24DCodes billed520
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#16 of 101
Median peer was paid$22.32M
This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018124,435$4.82M
2019121,353$5.06M
202087,561$5.07M
2021125,883$6.34M
2022133,873$5.82M
2023518,429$21.34M
2024incomplete375,249$13.95M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 14% 71,128 62,449 $8.97M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 64,882 61,472 $7.26M
96361 Intravenous infusion, hydration; each additional hour 11% 25,073 17,831 $6.90M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8.0% 60,599 49,731 $4.99M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.4% 39,573 36,309 $4.62M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4.9% 22,954 20,553 $3.06M
G0378 Hospital observation service, per hour 3.6% 29,431 13,807 $2.24M
J9271 Injection, pembrolizumab, 1 mg 3.4% 263 133 $2.10M
70450 Computed tomography, head or brain; without contrast material 2.3% 5,989 4,911 $1.43M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 10,113 9,609 $1.08M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 5,101 4,214 $1.03M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.6% 7,493 6,561 $993K
508 more codes
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.5% 5,166 $907K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 7,135 $883K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 3,648 $767K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.1% 3,412 $657K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,074 $618K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 8,798 $542K
80053 Comprehensive metabolic panel <1% 86,178 $537K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 5,729 $527K
59025 Fetal non-stress test <1% 3,440 $509K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 5,905 $505K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,652 $457K
J2350 Injection, ocrelizumab, 1 mg <1% 24 $455K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,438 $350K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 9,171 $343K
93975 <1% 2,615 $339K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,758 $273K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,829 $265K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,132 $256K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 2,582 $235K
70498 <1% 910 $222K
87631 <1% 2,307 $216K
96415 <1% 710 $209K
90839 <1% 1,488 $188K
99213 Doctor's office visit, returning patient (routine) <1% 4,773 $177K
70491 <1% 534 $160K
76770 <1% 1,035 $158K
81513 <1% 1,195 $153K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 625 $150K
93458 <1% 139 $145K
58661 <1% 88 $143K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 375 $132K
96127 <1% 1,442 $130K
93799 <1% 21,399 $114K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,257 $109K
76642 <1% 893 $105K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 303 $105K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 43,614 $103K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 79 $102K
96367 <1% 1,980 $101K
70551 Magnetic resonance imaging, brain; without contrast material <1% 706 $101K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 743 $99K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 227 $94K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 61 $93K
78815 Positron emission tomography (PET) for limited area imaging <1% 185 $91K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 85,628 $85K
58558 <1% 67 $85K
86850 <1% 4,616 $85K
84484 <1% 25,848 $81K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,848 $80K
0002A <1% 2,109 $79K
0001A <1% 2,122 $77K
93970 <1% 662 $76K
80048 Basic metabolic panel (calcium, ionized) <1% 13,146 $74K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 677 $74K
97161 <1% 2,303 $72K
96161 <1% 463 $71K
99214 Doctor's office visit, returning patient (more involved) <1% 1,575 $70K
97535 Self-care/home management training, each 15 minutes <1% 2,863 $69K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 4,990 $69K
71250 <1% 844 $68K
93798 <1% 1,450 $68K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 560 $67K
12001 <1% 429 $65K
93971 <1% 1,139 $63K
36415 Collection of venous blood by venipuncture <1% 86,693 $62K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 430 $62K
71046 Radiologic examination, chest; 2 views <1% 9,351 $61K
99222 Initial hospital care, per day, moderate complexity <1% 1,540 $60K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 668 $59K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 10,399 $58K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,856 $53K
74183 <1% 277 $53K
12011 <1% 334 $52K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 183 $52K
44970 <1% 24 $50K
99232 Hospital visit by a doctor, follow-up day <1% 2,650 $48K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,570 $48K
76536 <1% 477 $44K
J1756 Injection, iron sucrose, 1 mg <1% 1,357 $43K
86900 <1% 4,668 $43K
85027 <1% 17,873 $43K
96160 <1% 215 $39K
92551 <1% 769 $39K
88307 <1% 410 $39K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 331 $38K
71275 Computed tomographic angiography, chest, with contrast material <1% 130 $37K
54150 <1% 835 $36K
90651 <1% 729 $36K
84443 Thyroid stimulating hormone (TSH) <1% 4,765 $35K
19083 <1% 51 $35K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 29,056 $34K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 717 $34K
77063 Screening digital breast tomosynthesis, bilateral <1% 683 $33K
71045 Radiologic examination, chest; single view <1% 15,304 $32K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,925 $32K
82962 <1% 22,650 $32K
97165 <1% 936 $30K
82805 <1% 1,127 $30K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 28 $28K
76830 Ultrasound, transvaginal <1% 1,259 $27K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,802 $27K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,191 $27K
97802 <1% 607 $26K
C9290 Injection, bupivacaine liposome, 1 mg <1% 291 $26K
90670 <1% 3,741 $26K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 147 $26K
83735 <1% 26,938 $25K
99152 <1% 1,752 $25K
36561 <1% 28 $25K
90686 <1% 3,632 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,807 $24K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,623 $24K
80061 Lipid panel <1% 2,474 $23K
99219 <1% 667 $23K
74018 <1% 1,423 $23K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,941 $22K
93017 <1% 344 $22K
10060 <1% 140 $21K
77336 <1% 260 $21K
84702 <1% 5,055 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 2,578 $21K
97116 <1% 1,053 $21K
70486 <1% 838 $21K
82728 <1% 1,774 $20K
76882 <1% 209 $20K
77062 <1% 509 $20K
73610 <1% 1,708 $20K
81001 <1% 40,096 $19K
Q3014 Telehealth originating site facility fee <1% 729 $19K
84439 <1% 1,702 $19K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 851 $18K
72131 <1% 355 $18K
86140 <1% 3,953 $18K
86780 <1% 1,727 $18K
77061 <1% 464 $18K
87505 <1% 151 $17K
90715 <1% 1,690 $17K
64615 <1% 89 $16K
36430 <1% 71 $16K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 4,477 $16K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 123 $16K
90648 <1% 2,064 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 1,938 $15K
97162 <1% 531 $15K
72100 <1% 962 $14K
94060 <1% 240 $14K
87340 <1% 1,118 $14K
73630 <1% 1,583 $13K
73130 <1% 1,307 $13K
83540 <1% 1,871 $13K
73564 <1% 872 $13K
70496 <1% 951 $13K
90633 <1% 1,626 $12K
36591 <1% 426 $12K
86803 <1% 791 $12K
77065 Tomosynthesis, mammo <1% 686 $12K
73110 <1% 1,084 $12K
86762 <1% 430 $12K
P9016 Red blood cells, leukocytes reduced, each unit <1% 65 $11K
96416 <1% 105 $11K
72197 <1% 58 $11K
73030 <1% 1,477 $11K
90698 <1% 1,765 $11K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 670 $11K
96376 <1% 7,503 $11K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 514 $11K
76857 <1% 716 $10K
90935 Hemodialysis procedure with single evaluation by a physician <1% 74 $10K
49083 <1% 24 $10K
83550 <1% 1,852 $10K
82607 <1% 1,125 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,098 $10K
86901 <1% 4,668 $10K
74019 <1% 1,026 $10K
72141 <1% 74 $10K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 819 $10K
85610 <1% 12,135 $10K
87481 <1% 1,082 $10K
90472 Immunization administration, each additional vaccine (list separately) <1% 5,086 $10K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,200 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 67 $9K
71271 <1% 81 $9K
77300 <1% 14 $9K
96368 <1% 652 $9K
90680 <1% 2,261 $9K
96112 <1% 30 $9K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 623 $8K
99153 Mod sedat endo service >5yrs <1% 1,147 $8K
94660 <1% 141 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 13,089 $8K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,702 $8K
99221 <1% 292 $8K
73502 <1% 970 $8K
52000 <1% 12 $8K
82533 <1% 737 $8K
90677 <1% 363 $8K
43235 <1% 12 $8K
83880 <1% 3,734 $7K
73560 <1% 1,188 $7K
92552 <1% 100 $7K
82024 <1% 548 $7K
80069 <1% 709 $7K
77066 Tomosynthesis, mammo <1% 574 $7K
73590 <1% 956 $7K
82784 <1% 766 $7K
82570 <1% 1,210 $6K
90688 <1% 530 $6K
76801 <1% 391 $6K
0004A <1% 181 $6K
90723 <1% 1,561 $6K
80076 <1% 745 $6K
51798 <1% 862 $6K
A9270 Non-covered item or service <1% 4,359 $6K
99223 Prolong inpt eval add15 m <1% 124 $5K
99217 <1% 213 $5K
12002 <1% 35 $5K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,480 $5K
88341 <1% 119 $5K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 245 $5K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 96 $5K
87510 <1% 280 $5K
84100 <1% 2,316 $5K
87077 <1% 2,351 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,091 $5K
S9443 Lactation classes, non-physician provider, per session <1% 101 $4K
82077 <1% 4,250 $4K
0054A <1% 283 $4K
J2469 Injection, palonosetron hcl, 25 mcg <1% 913 $4K
0124A <1% 140 $4K
97166 <1% 192 $4K
83690 <1% 11,197 $4K
00840 <1% 891 $4K
58300 <1% 31 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,132 $4K
86923 <1% 121 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,168 $4K
86706 <1% 521 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 37 $4K
0071A <1% 115 $4K
74174 <1% 65 $4K
25600 <1% 13 $4K
83970 <1% 185 $4K
77080 <1% 67 $3K
J1815 Injection, insulin, per 5 units <1% 342 $3K
83655 <1% 179 $3K
94729 <1% 155 $3K
76870 <1% 343 $3K
J3490 Unclassified drugs <1% 222 $3K
J1610 Injection, glucagon hydrochloride, per 1 mg <1% 35 $3K
73080 <1% 472 $3K
0072A <1% 92 $3K
99253 <1% 74 $3K
73090 <1% 668 $3K
99239 Hospital discharge day management, more than 30 minutes <1% 82 $3K
73140 <1% 423 $3K
85652 <1% 1,123 $3K
73552 <1% 529 $3K
90480 <1% 153 $3K
81025 <1% 10,314 $3K
87660 <1% 283 $3K
93880 <1% 29 $3K
87070 <1% 1,991 $3K
90685 <1% 407 $3K
82950 <1% 190 $2K
90744 <1% 505 $2K
64450 <1% 19 $2K
73700 <1% 25 $2K
82550 <1% 2,151 $2K
84156 <1% 953 $2K
87653 <1% 163 $2K
72170 <1% 1,086 $2K
81003 <1% 3,369 $2K
99203 Doctor's office visit, new patient (routine) <1% 57 $2K
90697 <1% 255 $2K
90619 <1% 195 $2K
73060 <1% 491 $2K
0003A <1% 57 $2K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $2K
86038 <1% 128 $2K
80320 <1% 389 $2K
82746 <1% 618 $2K
85730 <1% 3,263 $2K
85018 <1% 1,387 $2K
86364 <1% 136 $2K
83605 <1% 3,620 $2K
96523 <1% 44 $2K
90696 <1% 248 $2K
90474 <1% 1,278 $2K
87186 <1% 1,640 $2K
99220 <1% 28 $2K
74220 <1% 31 $2K
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) <1% 42 $2K
90461 <1% 1,817 $2K
90710 <1% 379 $2K
72050 <1% 49 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,867 $2K
87493 <1% 123 $2K
82947 <1% 1,220 $2K
86258 <1% 97 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,446 $1K
J1453 Injection, fosaprepitant, 1 mg <1% 115 $1K
84145 <1% 845 $1K
87040 <1% 1,921 $1K
90656 <1% 190 $1K
99254 <1% 27 $1K
72040 <1% 89 $1K
85379 <1% 2,931 $1K
72128 <1% 42 $1K
90716 <1% 232 $1K
00731 <1% 598 $1K
82330 <1% 1,347 $1K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,213 $1K
83615 <1% 371 $1K
71101 <1% 186 $1K
84703 <1% 2,587 $1K
99215 Doctor's office visit, returning patient (complex) <1% 30 $1K
86003 <1% 28 $1K
82565 <1% 178 $1K
87205 <1% 1,094 $1K
99252 <1% 41 $1K
86703 <1% 755 $1K
99238 Hospital discharge day management, 30 minutes or less <1% 52 $1K
84132 <1% 1,899 $1K
82105 <1% 84 $1K
99381 <1% 92 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,722 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 17,555 $1K
96402 <1% 114 $925.74
82043 <1% 179 $925.53
87480 <1% 280 $902.57
J1644 Injection, heparin sodium, per 1000 units <1% 6,146 $882.17
86308 <1% 424 $865.59
82375 <1% 1,517 $833.99
84153 <1% 102 $830.91
82150 <1% 1,033 $821.94
80143 <1% 476 $814.94
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,240 $797.81
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 75 $790.89
82553 <1% 275 $786.59
01844 <1% 19 $774.66
74230 <1% 13 $773.97
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 105 $720.74
C9113 Injection, pantoprazole sodium, per vial <1% 716 $717.56
86704 <1% 79 $716.39
87522 Neg quan hep c or qual rna <1% 31 $709.18
84146 <1% 77 $645.85
00170 Anesthesia for intraoral procedures, including biopsy <1% 391 $644.13
84550 <1% 219 $608.92
73070 <1% 58 $607.91
94726 <1% 13 $580.15
87486 <1% 96 $575.92
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,352 $575.07
93321 <1% 17 $540.02
J2704 Injection, propofol, 10 mg <1% 7,779 $536.16
0064A <1% 22 $533.28
90707 <1% 165 $528.31
82435 <1% 1,051 $524.00
86870 <1% 14 $500.43
36416 <1% 2,672 $497.24
82378 <1% 88 $496.06
85045 <1% 211 $484.56
84165 <1% 134 $480.09
J3010 Injection, fentanyl citrate, 0.1 mg <1% 9,008 $458.95
83521 <1% 69 $456.67
72072 <1% 101 $452.62
92526 <1% 17 $450.01
90658 <1% 46 $432.12
84403 <1% 30 $429.48
84155 <1% 159 $409.88
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 424 $398.06
J0360 Injection, hydralazine hcl, up to 20 mg <1% 413 $393.85
99218 <1% 12 $387.06
92611 <1% 13 $385.01
J9045 Injection, carboplatin, 50 mg <1% 45 $384.63
86334 <1% 31 $355.01
87420 <1% 17 $351.79
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,428 $349.25
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 15,945 $343.51
84450 <1% 104 $342.27
84460 <1% 109 $333.34
90700 <1% 73 $332.75
80179 <1% 454 $327.59
87581 <1% 100 $320.07
00811 <1% 76 $317.22
84295 <1% 1,117 $285.37
82977 <1% 23 $284.86
99442 <1% 14 $283.53
83050 <1% 1,140 $278.52
J1940 Injection, furosemide, up to 20 mg <1% 585 $274.45
99441 <1% 27 $272.21
0052A <1% 30 $269.26
J2785 Injection, regadenoson, 0.1 mg <1% 294 $261.72
88304 <1% 581 $258.34
00400 <1% 127 $250.10
86355 <1% 42 $244.10
J0690 Injection, cefazolin sodium, 500 mg <1% 3,155 $239.25
88342 <1% 385 $236.80
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 811 $225.98
77001 <1% 137 $217.28
82010 <1% 631 $215.23
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 438 $208.07
73000 <1% 16 $205.98
87808 <1% 90 $203.27
0051A <1% 23 $190.18
82140 <1% 105 $186.73
82525 <1% 48 $180.74
J0780 Injection, prochlorperazine, up to 10 mg <1% 795 $172.85
80177 <1% 109 $168.40
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,278 $165.80
J3370 Injection, vancomycin hcl, 500 mg <1% 702 $159.94
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 875 $142.19
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,516 $137.68
85014 <1% 16 $133.96
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 412 $126.86
J2060 Injection, lorazepam, 2 mg <1% 1,131 $122.56
84630 <1% 22 $120.58
80164 <1% 50 $119.80
84481 <1% 32 $117.82
82270 <1% 222 $111.22
87641 <1% 87 $109.73
94760 <1% 7,079 $107.28
90734 <1% 29 $105.60
J1790 Injection, droperidol, up to 5 mg <1% 1,073 $103.59
74022 <1% 13 $102.02
96417 <1% 802 $94.57
87430 <1% 24 $92.04
84425 <1% 16 $87.66
91300 <1% 4,537 $85.25
87640 <1% 87 $84.60
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,405 $83.88
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,752 $82.18
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 667 $74.57
86665 <1% 15 $69.03
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 77 $68.79
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,851 $67.86
J3480 Injection, potassium chloride, per 2 meq <1% 1,397 $66.92
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,431 $64.78
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 990 $56.53
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 36 $55.59
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,435 $55.37
82040 <1% 12 $50.66
J2470 Injection, pantoprazole sodium, 40 mg <1% 149 $46.06
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 119 $41.80
81002 <1% 558 $39.31
J1596 Injection, glycopyrrolate, 0.1 mg <1% 628 $38.74
J7030 Infusion, normal saline solution , 1000 cc <1% 705 $38.29
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 647 $36.70
C1769 Guide wire <1% 1,225 $33.65
J7999 Compounded drug, not otherwise classified <1% 15 $33.59
80175 <1% 13 $30.78
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 297 $29.75
C1729 Catheter, drainage <1% 236 $26.82
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 785 $26.25
94761 <1% 64 $22.94
87529 <1% 12 $19.59
87088 <1% 45 $17.82
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 424 $17.06
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 117 $15.87
J7050 Infusion, normal saline solution, 250 cc <1% 2,344 $14.70
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,828 $14.20
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 788 $12.29
J1920 Injection, labetalol hydrochloride, 5 mg <1% 15 $9.01
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 87 $6.54
J0456 Injection, azithromycin, 500 mg <1% 282 $5.98
J1630 Injection, haloperidol, up to 5 mg <1% 40 $5.66
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 40 $5.35
J1171 Injection, hydromorphone, 0.1 mg <1% 103 $5.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 1,138 $4.12
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 254 $3.51
91307 <1% 319 $2.54
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 96 $2.52
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 119 $1.81
91305 <1% 359 $1.39
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 57 $1.03
91312 <1% 100 $0.55
91306 <1% 20 $0.14
3079F 0% 199 $0.00
A4648 Tissue marker, implantable, any type, each 0% 204 $0.00
3074F 0% 2,459 $0.00
00790 0% 229 $0.00
C1781 Mesh (implantable) 0% 21 $0.00
00126 0% 18 $0.00
3075F 0% 206 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 99 $0.00
76377 0% 52 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 64 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 34 $0.00
00142 0% 13 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 0% 43 $0.00
00952 0% 94 $0.00
3044F 0% 29 $0.00
3077F 0% 304 $0.00
3078F 0% 2,902 $0.00
87220 0% 47 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 242 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 391 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 14 $0.00
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 0% 12 $0.00
C2625 Stent, non-coronary, temporary, with delivery system 0% 117 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 234 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 282 $0.00
88112 0% 54 $0.00
J9190 Injection, fluorouracil, 500 mg 0% 107 $0.00
88302 0% 20 $0.00
87210 0% 49 $0.00
C1788 Port, indwelling (implantable) 0% 45 $0.00
29125 0% 17 $0.00
00910 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.